ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VVY Vivoryon Therapeut

2.11
0.82 (63.57%)
May 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Vivoryon Therapeut VVY Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.82 63.57% 2.11 11:40:00
Open Price Low Price High Price Close Price Prev Close
1.32 1.32 2.465 2.11 1.29
more quote information »

Recent News

Date Time Source Heading
5/23/202401:00GLOBEVivoryon Therapeutics N.V. Reports Q1 2024 Financial Results..
5/15/202401:00GLOBEVivoryon Therapeutics N.V. to Report Q1 2024 Financial..
5/08/202401:00GLOBEVivoryon Therapeutics N.V. to Hold its 2024 Annual General..
4/24/202401:00GLOBEVivoryon Therapeutics N.V. Reports Full Year 2023 Financial..
4/16/202401:00GLOBEVivoryon Therapeutics N.V. to Report Full Year 2023..
3/15/202402:00GLOBEVivoryon Therapeutics N.V. Announces Changes to Board..
3/04/202401:00GLOBEVivoryon Therapeutics N.V. Provides Update on VIVIAD Phase..
1/08/202401:00GLOBEVivoryon Therapeutics N.V. to Host Investor Meetings in..
12/06/202301:00GLOBEVivoryon Therapeutics N.V. Reports Third Quarter 2023..
11/28/202301:00GLOBEVivoryon Therapeutics N.V. to Report Q3 2023 Financial..
11/07/202301:00GLOBEVivoryon Therapeutics N.V. to Present at Upcoming Investor..
10/26/202301:00GLOBEVivoryon Therapeutics N.V. Provides Comprehensive Progress..
10/23/202301:00GLOBEVivoryon Therapeutics N.V. Reports Positive Outcome from..
10/17/202309:32GLOBEVivoryon Therapeutics N.V. Shares Highlights from Virtual..
10/05/202301:00GLOBEVivoryon Therapeutics N.V. Announces Virtual R&D Event with ..
9/15/202307:57GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting..
9/07/202301:00GLOBEVivoryon Therapeutics N.V. Reports H1 2023 Financial Results..
8/31/202301:00GLOBEVivoryon Therapeutics N.V. to Report Half Year 2023..
8/04/202317:35GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting to..
8/04/202317:30GLOBEVivoryon Therapeutics N.V. Announces Proposed Appointment of..
7/16/202303:00GLOBEVivoryon Therapeutics N.V. Shares Clinical Development..
6/21/202312:02GLOBEVivoryon Therapeutics N.V. Reports Outcome of 2023 Annual..
6/15/202311:49GLOBEVivoryon Therapeutics N.V. Announces CEO Transition Plan
6/01/202301:00GLOBEVivoryon Therapeutics N.V. to Participate in Upcoming..
5/26/202301:39GLOBEVivoryon Therapeutics Successfully Completes Private..